CYP2E1 and Schnyder corneal dystrophy: Furthermore, a possible cooperation between the drug and arachidonic metabolisms in the pathogenesis of SCD has been highlighted, since some genes (for instance CYP2E1, CYP2C9, and CYP2J2) displaying variants with a statistical significance are involved in both metabolic processes (Supplementary Table S3).